Sort
15,273 grants matching “antimicrobial resistance”
Development of adjunctive therapies directed at S. aureus amidases
$222,832Blaise R Boles · University Of Iowa · R21 · FY2014 · AI
Non-Self Recognition and Immune Suppression in Drosophila
$222,755Shubha Govind · City College Of New York · S06 · FY2008 · GM
Project 2 - Toxicant-Stimulated Disruption of Gestational Tissues with Implications for Adverse Pregnancy Outcomes
$222,751Rita Karen Loch-Caruso · Northeastern University · P42 · FY2022 · ES
Antimicrobial, anti-inflammatory, analgesic, silver-based, electrospun bandages for superior wound healing
$222,750Carolyn Louise Cannon · Texas A&M University Health Science Ctr · R21 · FY2020 · AI
Manipulation of host complement by Clostridium difficile spores - an immune evasion strategy.
$222,750Yi Xu · Texas A&M University Health Science Ctr · R21 · FY2017 · AI
Streptococcus mutans strain susceptibility differences to host defense peptides
$222,750Jeffrey A Banas · University Of Iowa · R21 · FY2011 · DE
Defining the molecular mechanisms of MacAB in protection of Salmonella from oxidative stress
$222,750Helene L Andrews-Polymenis · Texas A&M University Health Science Ctr · R21 · FY2016 · AI
Novel membrane remodeling systems in Actinobacteria and their role in antibiotic resistance
$222,738Herve Roy · University Of Central Florida · R21 · FY2019 · AI
The role of peptide signaling in Enterococcus faecalis biofilm development
$222,492Lynn E Hancock · University Of Kansas Lawrence · R21 · FY2017 · AI
Prevention of UTI With A Vaginal Probiotic
$222,474Walter E Stamm · University Of Washington · P01 · FY2007 · DK
Reconstitution of Two-membrane Transporters into High-density Lipoprotein Particl
$222,450Helen I. Zgurskaya · University Of Oklahoma · R21 · FY2011 · AI
Staphylococcus aureus ribosomal protein processing, a potential new drug target
$222,450Gail E Christie · Virginia Commonwealth University · R21 · FY2015 · AI
Project 3: Immunoassays for Human and Environmental Monitoring
$222,413Bruce D Hammock · University Of California At Davis · P42 · FY2010 · ES
Mucosal immunization for cross-protection against pneumonic burkholderia
$222,278Steven W. Dow · Colorado State University · U54 · FY2011 · AI
Novel Context-Activated Protide Anti-Infectives
$222,262Michael R Yeaman · Novadigm Therapeutics, Inc. · R41 · FY2007 · AI
Characterization of F. tularensis Virulence Genes
$222,236Karl E Klose · University Of Texas San Antonio · P01 · FY2007 · AI
Designed Host Defense Peptides for the Treatment of Bacterial Keratitis
$222,179Louis Edward Clemens · Riptide Bioscience, Inc. · R43 · FY2014 · EY
Characterization of F. tularensis Virulence Genes
$222,176Karl E Klose · University Of Texas San Antonio · P01 · FY2008 · AI
AMAUTA HEALTH INFORMATICS RESEARCH AND TRAINING PROGRAM
$222,120Ann Marie Kimball · University Of Washington · D43 · FY2007 · TW
Mechanism of streptococcus virulence regulation by bacterial peptide signals
$222,075Muthiah Kumaraswami · Methodist Hospital Research Institute · R21 · FY2013 · AI
Rapid identification and antibiotic susceptibility testing of sepsis pathogens
$222,008David A Haake · University Of California Los Angeles · R21 · FY2015 · AI
Wound healing mechanisms modulated by novel antimicrobial Peptides
$222,000Anne Kasus-Jacobi · University Of Oklahoma Hlth Sciences Ctr · R21 · FY2017 · EY
Extreme Halophiles: A Potential Reservoir of New Antibiotics
$222,000Stephen M Beckstrom-Sternberg · Northern Arizona University · R15 · FY2007 · AI
The Twort-like bacteriophages of Staphylococcus aureus: paradigm phages for novel therapeutics
$222,000Jason J. Gill · Texas A&M Agrilife Research · R21 · FY2015 · AI
Volatile Metabolite-Based Detection of Clostridium difficile Infection
$221,875Sophia Koo · Brigham And Women'S Hospital · R21 · FY2016 · AI